Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

691
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
691
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

779
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
779
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

563
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated vehicle access control system using license plate recognition.

Scientific reports·2026
Same author

Synchronization and extreme events in multiplex FitzHugh-Nagumo networks under heterogeneous noise.

Chaos (Woodbury, N.Y.)·2026
Same author

Climate-induced shifts in habitat suitability of forest types and adaptation strategies in the Western Ghats of Tamil Nadu, India.

Scientific reports·2026
Same author

Retro-walking improves neck disability and spatiotemporal variables of gait in individuals with chronic mechanical neck pain.

Journal of bodywork and movement therapies·2025
Same author

Automated mechanical ventilator design and analysis using neural network.

Scientific reports·2025
Same author

Transmission dynamics of fractional order SVEIR model for African swine fever virus with optimal control analysis.

Scientific reports·2024

Related Experiment Video

Updated: Mar 29, 2026

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

983

Renal Transplantation With Final Allocation Based on the Virtual Crossmatch.

C P Johnson1, J J Schiller2, Y R Zhu1

  • 1Department of Surgery (Division of Transplantation), Medical College of Wisconsin, Milwaukee, WI.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|November 26, 2015
PubMed
Summary
This summary is machine-generated.

Solid phase immunoassays (SPI) are effective for detecting HLA antibodies in kidney transplants. This study shows SPI can replace flow cytometric crossmatch (FCXM) for donor-recipient compatibility, ensuring successful long-term graft survival.

More Related Videos

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.3K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.9K

Related Experiment Videos

Last Updated: Mar 29, 2026

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

983
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.3K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.9K

Area of Science:

  • Transplantation immunology
  • Nephrology
  • Clinical diagnostics

Background:

  • Solid phase immunoassays (SPI) are standard for detecting HLA antibodies.
  • Flow cytometric crossmatch (FCXM) is the traditional method for assessing donor-recipient compatibility in renal transplantation.
  • A shift in protocol has occurred, prioritizing SPI over FCXM for final allocation decisions since 2005.

Purpose of the Study:

  • To evaluate long-term graft outcomes in kidney transplant recipients.
  • To compare outcomes between FCXM-positive (FCXM+) and FCXM-negative (FCXM-) recipients under a protocol using SPI for allocation.
  • To determine if crossmatch status impacts graft survival and acute rejection rates.

Main Methods:

  • Analysis of 508 consecutive kidney transplants where allocation was based on SPI.
  • Categorization of recipients into FCXM+ (n=54) and FCXM- (n=454) groups.
  • Assessment of primary outcomes: graft survival and acute rejection within 1 year, with a median follow-up of 7.1 years.

Main Results:

  • FCXM+ recipients had higher rates of sensitization and specific risk factors (e.g., longer dialysis duration, retransplants).
  • Despite risk factor differences, 5-year actual graft survival was comparable (87% FCXM+ vs. 84% FCXM-).
  • Acute rejection within 1 year was similar between groups (13% FCXM+ vs. 12% FCXM-); crossmatch status did not predict outcomes.

Conclusions:

  • Renal transplantation can be successfully performed using SPI as the definitive test for donor-recipient compatibility.
  • The study supports the use of SPI, potentially simplifying the pre-transplant compatibility assessment process.
  • Long-term graft survival is not adversely affected by relying on SPI over FCXM for allocation decisions.